Document:

EX-10.1 Settlement Agreement

 

Exhibit 10.1

SETTLEMENT AGREEMENT

     This SETTLEMENT AGREEMENT (the “Agreement”) is made and entered into as of March 3,
2008 by and among UBS Securities LLC and UBS Loan Finance LLC (collectively, “UBS”), The Finish
Line, Inc. and Headwind, Inc. (collectively “Finish Line”) and Genesco Inc. (“Genesco”). UBS,
Finish Line, and Genesco are individually referred to herein as a “Party,” and collectively as the
“Parties.”

W I T N E S S E T H

     WHEREAS, UBS has filed an action captioned UBS Securities LLC et al. v. The Finish Line, Inc.
et al., Civil Action No. 07 Civ. 10382, in the United States District Court for the Southern
District of New York (the “New York Action”) against Finish Line and Genesco seeking costs and a
declaration that (1) UBS is relieved of its obligations under the Bank and Bridge Facilities
Commitment Letter by and between UBS and Finish Line, dated June 17, 2007 (the “Commitment
Letter”), as extended, and (2) the Commitment Letter is void or voidable by UBS as a result of the
failure of conditions to closing and other requirements under the Commitment Letter; and

     WHEREAS, Finish Line has asserted six counterclaims against UBS in the New York Action; and

     WHEREAS, there is also another lawsuit currently pending among UBS, Genesco, and Finish Line
in the Chancery Court for the State of Tennessee, Twentieth Judicial District, Davidson County,
Part III, captioned Genesco Inc. v. The Finish Line, Inc. et al., No. 07-2137-II(III) (the
“Tennessee Action”); and

 

 

     WHEREAS, all Parties deny any and all liability in connection with the subject matter of the
New York Action and the Tennessee Action; and

     WHEREAS, all Parties wish to settle any and all claims between them, whether or not related to
the New York Action or the Tennessee Action in order to avoid the expense, inconvenience, and
distraction of further litigation; and

     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the Parties covenant and agree, in full and final settlement of the New York
Action and the Tennessee Action, whether in those Actions or otherwise, and all claims that have or
could have been asserted by UBS, Genesco, and Finish Line, as follows:

     1. Payment. In settlement of the claims asserted by the Parties and in consideration
of the termination of the agreements specified in Paragraph 3 herein, (1) UBS and Finish Line,
together, shall pay Genesco the sum of $175,000,000 (USD), to be deposited into an account
maintained by Genesco. In addition, Finish Line, as further consideration for settlement of the
claims against it and termination of the Merger Agreement, shall transfer to Genesco the number of
duly authorized, validly issued shares of Finish Line Class A Common Stock equal to twelve percent
(12%) of the post-issuance Finish Line common stock issued and outstanding, such issued and
outstanding shares constituting 6,518,971 shares (“Shares”). The aforementioned payments and
transfers shall be made no later than 5:00 p.m. Eastern Standard Time, Friday, March 7, 2008. In
addition, Finish Line, without undue delay, shall undertake reasonable best efforts to cause such
Shares to be registered and listed for trading and, as soon as reasonably practicable thereafter,
Genesco will use its reasonable best efforts to distribute such

2

 

Shares to its common shareholders. There shall be no further payment from UBS or Finish Line
to Genesco or from any of the Parties to each other. All Parties shall bear their own legal fees,
costs, and expenses and waive any and all claims for reimbursement, indemnification or
contribution, except as provided in this Agreement.

     2. Release of Claims. Except for the obligations set forth in this Agreement, and
except as provided in Paragraph 1 above, the Parties each hereby release and forever discharge each
other and the others’ respective members, officers, directors, employees, attorneys, advisors,
agents, parents, subsidiaries, affiliates, heirs, executors, administrators, predecessors,
successors and assigns, from all actions, causes of action, suits, debts, dues, sums of money,
accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, agreements,
promises, variances, trespasses, damages, judgments, executions, claims, and demands whatsoever, in
law or equity, which against each other they ever had, now have or hereafter can, shall or may
have, by reason of any matter, cause or thing whatsoever, from the beginning of the world to the
day this Agreement is executed by all Parties, including, but not limited to those related, in any
way, to the claims asserted or that could have been asserted by the Parties in the New York Action
or Tennessee Action.

     It is the intention of the Parties to extinguish all Released Claims and consistent with such
intention, the Parties hereby expressly waive their rights to the fullest extent permitted by law,
to any benefits of the provisions of Section 1542 of the California Civil Code or any other similar
state law, federal law or principle of common law, which may have the effect of limiting the
releases set forth herein. Section 1542 of the California Civil Code provides:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES
NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING

3

 

THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS
SETTLEMENT WITH THE DEBTOR.

The Parties acknowledge that they may discover facts in addition to or different from those that
they now know or believe to be true with respect to the subject matter of the releases granted
herein, but acknowledge that it is their intention to fully, finally and forever settle, release
and discharge any and all claims hereby known or unknown, suspected or unsuspected, which do or do
not exist, or heretofore existed, and without regard to the subsequent discovery or existence of
such additional or different facts.

     3. Termination of Agreements. Upon execution of this Agreement, all rights and
obligations under the Agreement and Plan of Merger by and among Finish Line and Genesco, dated June
17, 2007 (the “Merger Agreement”), the Commitment Letter, the Bank and Bridge Facilities Fee
Letter, dated June 17, 2007 (“Fee Letter”), the Engagement Letter between UBS Securities LLC and
The Finish Line, Inc., dated June 17, 2007 (“Engagement Letter”), the Amendment to Bank and Bridge
Facilities Commitment Letter (“Amendment Letter”), dated October 12, 2007, the letter agreement
between UBS Securities LLC and The Finish Line, Inc., dated October 3, 2006 (the “October 2006 M&A
Engagement Letter”), the Indemnification Agreement between UBS Securities LLC and The Finish Line,
Inc., dated October 3, 2006 (the “October 2006 Indemnification Agreement”), the letter agreement
between UBS Securities LLC and The Finish Line, Inc., dated June 11, 2007, as amended (the “June
2007 M&A Engagement Letter”), the Indemnification Agreement between UBS Securities LLC and The
Finish Line, Inc., dated June 11, 2007 (the “June 2007 Indemnification Agreement”), and the
Confidentiality Agreement between UBS Securities LLC and The Finish Line, Inc., dated September 25,
2006 (the “Confidentiality Agreement”), running to any party whatsoever, including third party

4

 

beneficiaries, if any, whether current or future, intended or unintended, shall terminate without
cost or fee without further action by the respective parties thereto, even if such rights were to
have survived termination of any of the foregoing agreements.

     4. Dismissal of the Litigation. Simultaneous with the execution of this Agreement,
the Parties’ respective counsel shall execute a Stipulation of Dismissal dismissing the New York
Action, with prejudice, pursuant to Rule 41(a)(1)(ii) of the Federal Rules of Civil Procedure. The
Parties’ respective counsel shall also execute a Stipulation of Dismissal dismissing the Tennessee
Action, with prejudice, pursuant to Rule 41 of the Tennessee Rules of Civil Procedure. Counsel for
Finish Line shall hold such stipulations in escrow pending receipt by Genesco of the funds and
stock referenced in Paragraph 1, whereupon Finish Line shall cause such stipulations to be filed
with the New York and Tennessee courts, respectively. Genesco will not oppose any request or
motion to vacate the Court’s December 27, 2007 and January 2, 2008 Orders in the Tennessee Action.

     5. Discovery Materials. Upon the execution of this Agreement by all Parties, and
unless otherwise prohibited by law, each Party shall destroy or return to the others all documents
and other materials that the other Party produced, whether in due diligence, in contemplation of
the merger, in the New York or Tennessee Actions, or for any other purpose. If a Party elects to
destroy rather than return documents, the documents shall be destroyed no later than thirty (30)
days following the dismissal of the Tennessee Action and the New York Action and any related
shareholder litigation, government investigation or regulatory proceeding. The Party destroying
the documents shall immediately provide written confirmation that the documents have been
destroyed.

5

 

     6. No Assignment of Claims or Interest. The Parties represent and warrant that they
have not assigned and will not assign any claims covered by this Agreement or any interest therein
to any other person or entity, and that there are no liens or attachments on the proceeds to be
paid under this Agreement or any of the claims covered by this Agreement. In the event any person
or entity shall claim a lien or interest in the monies paid to any party under this Agreement,
Genesco shall indemnify and defend UBS and Finish Line for and against any claims asserted by such
person or entity against UBS or Finish Line, and the existence of such lien or interest shall not
affect in any way the terms and effect of the releases that Genesco has granted UBS and Finish Line
in this Agreement. Similarly, UBS and Finish Line, respectively, shall indemnify and defend
Genesco for and against any claims asserted against Genesco by any person or entity claiming to
have had any lien or legal interest in the proceeds UBS and Finish Line respectively paid to
Genesco under this Agreement that existed prior to the payment of the proceeds. The existence of
such pre-existing lien or interest shall not affect in any way the terms and effect of the releases
that UBS and Finish Line have granted Genesco in this Agreement.

     7. No Admission of Liability or Wrongdoing. This Settlement Agreement is made solely
for the purposes of resolving the differences between the Parties to it, and nothing in this
Agreement shall be construed as or constitute an admission of liability by, or evidence of damage
to, any Party hereto, all liability being expressly denied. Furthermore, nothing in this Agreement
shall be construed as or constitute an admission of the validity or enforceability of any claims or
demands that were made or could have been made in the New York or Tennessee Actions. This
Agreement shall not be admissible in any legal proceeding except to enforce its terms.

6

 

     8. Standstill Agreement. Genesco and Finish Line will not, and will not cause their
affiliates to assist, provide, or arrange financing to or for others or encourage others to,
directly or indirectly, acting alone or in concert with others (whether publicly or privately), for
a period of three years from the date of this Settlement Agreement, unless specifically requested
in writing in advance by Genesco or Finish Line: (i) acquire or agree, offer, seek or propose to
acquire (or request permission to do so) ownership (including, but not limited to, beneficial
ownership as defined in 13d-3 under the Securities Exchange Act of 1934, as amended) of any of the
assets, indebtedness or business of the other or any subsidiaries thereof or any securities of the
other or any subsidiary or affiliate thereof or any rights or options to acquire such ownership
(including from a third party), including without limitation, by means of tender or exchange offer,
(ii) offer, seek or propose a merger, consolidation, recapitalization, reorganization, business
combination or similar transaction, or any other extraordinary transaction with or involving the
other or any subsidiary or affiliate thereof, or any successor entities thereto, (iii) seek or
propose to influence or control the management, the Boards of Directors, or the policies of the
other or any subsidiary or affiliate thereof or to obtain representation on the other’s Boards of
Directors, or solicit, or participate in the solicitation of, any proxies or consents with respect
to any securities of the other or any subsidiary or affiliate thereof, or (iv) enter into any
discussions, negotiations, arrangements or understandings with any third party with respect to any
of the foregoing.

     9. Tax Issues. Genesco agrees that neither UBS nor Finish Line shall have any
responsibility whatsoever to any federal, state or local taxing authority for any tax liability or
consequences, if any, to Genesco or any other person arising from the payment to Genesco of the

7

 

consideration provided for herein. Genesco will provide both UBS and Finish Line with a
fully-executed W-9 upon the complete execution of this Agreement by all Parties.

     10. Binding Effect. This Agreement shall be binding upon and shall inure to the
benefit of each of the Parties hereto and their heirs, executors, administrators, representatives,
agents, successors, assigns, and any entity into or with which any party hereto may merge or
consolidate.

     11. Exception for Share Interest: Genesco represents to Finish Line that it is
acquiring the Shares for investment purposes and has no present intent to sell, distribute or
otherwise transfer the Shares acquired pursuant to this Agreement other than as a distribution to
its shareholders after the Shares have been properly registered under the Securities Act of 1933,
as amended (the “1933 Act”) and applicable state securities laws. Genesco has been advised and
fully understands that the Shares being issued to it pursuant to this Agreement by Finish Line have
not been registered under the 1933 Act by reason of an exemption under the 1933 Act which depends
upon its investment intent regarding the securities being purchased. Genesco further represents
and warrants that it has been advised about, is familiar with, and has had access to all
information regarding the affairs of the Finish Line it deems necessary to enter into this
Agreement. The stock certificate(s) for the shares to be issued to Genesco pursuant to this
Agreement shall bear the following legend:

The securities represented by this certificate have not been
registered under the Securities Act of 1933, as amended, or the
securities laws of any state. As a result, the securities
represented by this certificate may not be sold or transferred in
the absence of registration under such laws or an opinion from legal
counsel satisfactory to the Corporation that such registration is
not required.

     12. Entire Agreement. This Agreement contains the entire understanding of the
Parties, except for any agreement that may be agreed to by Finish Line and UBS regarding

8

 

the apportionment of the $175 million to be paid to Genesco. There are otherwise no
restrictions, promises, representations, warranties, covenants, or undertakings concerning the
subject matter of this Agreement other than those expressly set forth herein. This Agreement
supersedes all prior agreements and understandings between or among any of the Parties with respect
to the subject matter hereof.

     13. Amendments. Neither this Agreement nor any of its terms may be modified or
amended except in writing executed by all of the Parties with the same formalities as this
Agreement.

     14. No Waiver. Failure by any Party to resort to any remedy referred to herein, or to
which the Party may otherwise be entitled, shall not be construed as a waiver of any other right or
remedy to which such Party may be entitled under this Agreement or otherwise. No written waiver
signed by all of the Parties shall excuse the performance of an act other than those specified
therein. The failure of any Party to enforce, or delay by any Party in enforcing, any of its
rights under this Agreement shall not be deemed a continuing waiver or modification thereof and any
Party may, within the time provided by applicable law, commence appropriate legal proceedings or
validly existing, as provided herein to enforce any and all of such rights.

     15. Authorization. The parties hereto expressly warrant and represent that the
execution of this Agreement is fully authorized by each of them; that each of the persons executing
this Agreement has the necessary and appropriate authority to do so; that there are no pending
agreements, transactions, or negotiations to which either of them is a party that would render this
Agreement or any part thereof void, voidable or unenforceable; and that no authorization, consent
or approval of any governmental entity is required to make this Settlement

9

 

Agreement valid and binding upon them. UBS, Finish Line, and Genesco expressly warrant and
represent that they are corporations in good standing in their respective places of domicile.

     16. Representation By Counsel. Each of the Parties also represents and agrees that it
or he has been represented by competent counsel in the making of this Agreement, and that such
counsel, and the Party itself or himself, has reviewed this Agreement in its entirety prior to its
execution. Each of the parties hereto warrants, represents, and agrees that it is entering into
this Agreement with full knowledge of the terms and provisions of this Agreement.

     17. Joint Drafting. The Parties agree that this Agreement shall be deemed to have
been jointly drafted by them, so that any ambiguity shall not be construed against any Party on the
basis of the identity of the drafter of any provision of this Agreement or the Agreement as a
whole.

     18. Severability. If any provision of this Agreement is held by a court of competent
jurisdiction to be invalid, void or unenforceable, the remainder of the provisions shall remain in
full force and effect and shall in no way be affected, impaired or invalidated; provided, however,
that in the event Paragraph 2 above (Release of Claims) is held, in whole or in part, to be
invalid, void or unenforceable as to any claims that were or could have been asserted by Genesco,
then Genesco shall be obligated to return immediately to UBS and Finish Line the full amount of the
payment and stock transferred to it set forth in Paragraph 1 above.

     19. Counterparts. This Agreement may be executed in any number of duplicate originals
and each such duplicate original shall be deemed to constitute but one and the same instrument.

10

 

     20. Headings. The headings set forth in this Agreement are for convenience of
reference only and shall not be deemed a part of, or considered, in construing or interpreting this
Agreement.

     21. Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New York, without regard to choice of law and conflicts of law
principles, to the extent that federal law does not apply. Any action based on this Agreement or
to enforce any of its terms shall be brought in the United States District Court for the Southern
District of New York, which shall retain exclusive venue and exclusive jurisdiction over all such
disputes. The parties hereto consent to the personal jurisdiction and venue of the federal courts
in the State of New York.

     22. Breach. Each Party acknowledges that each other Party is relying on this
Agreement and the releases contained herein in agreeing to the Settlement. No breach by any Party
of any undertaking hereunder shall revoke or terminate the undertakings and releases hereunder in
favor of any non-breaching Party, and each Party agrees that the only remedy available for breach
of any undertaking and release hereunder shall be for money damages or specific performance against
the breaching Party only.

11

 

IN WITNESS WHEREOF, it is hereby agreed to by the undersigned as of March 3, 2008.

	 	 	 	 	 	 	 
	By:

	 	/s/ Alan H. Cohen
	 	By:	 	/s/ Hal N. Pennington
	 

	 	 
	 	 	 	 
	 

	 	Alan H. Cohen
	 	 	 	Hal N. Pennington
	 

	 	President and CEO
	 	 	 	Chairman & CEO
	 

	 	The Finish Line, Inc.
	 	 	 	Genesco Inc.

I declare under penalty of perjury that the foregoing is
true and correct. Executed on March 3, 2008

	 	 	 	 	 
	 	 	 
	By:  	/s/ Steven D. Smith	 	 
	 	Steven D. Smith                                           	 	 
	 	Joint Head of Global Leverage Finance

and 	 	 
	 

I declare under penalty of perjury that the foregoing is
true and correct. Executed on March 3, 2008

	 	 	 	 	 
	 	 	 
	By:  	/s/ James E. Odell 	 	 
	 	James E. Odell                                            	 	 
	 	General Counsel, the Americas

UBS Securities LLC and UBS Loan Finance LLC 	 	 

12EX-10.19 EMPLOYMENT AND CONFIDENTIALITY AGREEMENT

 

Exhibit 10.19

EMPLOYMENT AGREEMENT

          This EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of this 1st day of
December 2006 (the “Effective Date”), by and between S1 Corporation, a Delaware corporation (the
“Company”), and Neil Underwood, individual (the “Employee”).

          WHEREAS, the Company and the Employee desire to enter into this Employment Agreement to set
out the terms and conditions for the employment relationship of the Employee with the Company from
and after the Effective Date; and

          WHEREAS, the board of directors of the Company (the “Board”) has approved and authorized the
Company’s execution, delivery and performance of this Agreement.

          NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and
other good and valuable consideration, the receipt and sufficiency of which hereby are
acknowledged, the parties hereto agree as follows:

          1. Employment Agreement. On the terms and conditions set forth in this Agreement, the
Company agrees to employ the Employee and the Employee agrees to be employed by the Company for the
Employment Period set forth in Section 2 hereof and in the position and with the duties set forth
in Section 3 hereof. Terms used herein with initial capitalization not otherwise defined are
defined in Section 20 below.

          2. Term. The initial term of employment under this Agreement shall be for a
three-year period commencing on the Effective Date (the “Initial Term”). The term of employment
shall be automatically renewed for an additional consecutive 12-month period (the “Extended Term”)
as of the first and every subsequent anniversary of the Effective Date, unless and until either
party provides written notice to the other party in accordance with Section 10 hereof not less than
90 days before such anniversary date that such party is terminating the term of employment under
this Agreement (“Non-Renewal”), which termination shall be effective as of the end of such Initial
Term or Extended Term, as the case may be, or until such term of employment is otherwise sooner
terminated as hereinafter set forth. Such Initial Term and all such Extended Terms are
collectively referred to herein as the “Employment Period.” A notice of Non-Renewal given by
either party to this Agreement shall not be deemed a termination of the Employee’s employment for
purposes of Section 9 of this Agreement unless otherwise expressly provided in such notice of
Non-Renewal. The Company’s obligations under Section 9 hereof shall survive the expiration or
termination of the Employment Period.

          3. Position and Duties. The Employee shall initially serve as the General
Manager/Vice President of the Company. The Employee acknowledges that the Company may, at its sole
discretion, change the Employee’s title, job duties and responsibilities and reporting as the
Company sees fit in its sole discretion. In any role in which the Employee is employed with the
Company, the Employee shall render executive, policy and other management services to the Company
of the type customarily performed by persons serving in such capacity. The Employee shall initially
report to the President of the Enterprise Business Unit of the Company unless otherwise determined
by the Company. The Employee shall also perform such other duties with the Company and with any
Subsidiary as the CEO of the Company or the Board may from time to time reasonably determine and
assign to the Employee. The Employee shall devote the Employee’s reasonable best efforts and
substantially full business time to the performance of the Employee’s duties and the advancement of
the business and affairs of the Company. The Employee agrees that during the Employment Period he
or she will not be entitled to additional compensation for serving as a member of the board of
directors of the Company or any Subsidiary if he or she is elected to serve thereon.

          4. Place of Performance. In connection with the Employee’s employment by the Company,
the Employee shall be based at the offices of the Company in Atlanta, Georgia, except as otherwise
agreed by the Employee and the Company and except for reasonable travel on Company business.

 

 

          5. Compensation and Benefits; Stock Options.

               (a) Base Salary. During the Employment Period, the Company shall pay to the Employee
an annual base salary (the “Base Salary”) at the rate of $200,000.00 per year. The Base Salary
will be reviewed annually and may be increased at the discretion of the Company. The Base Salary
shall be payable semi-monthly or in such other installments as shall be consistent with the
Company’s payroll procedures.

               (b) Annual Bonus. The Employee will be eligible to receive an annual bonus, payable
no later than the end of the first fiscal quarter of each calendar year during the Employment
Period (pro-rated for any period that is less than 12 months) of up to $200,000.00 for such
calendar year, based on the attainment of specific Company and individual performance targets as
may be assigned by the Company annually.

               (c) Benefits. During the Employment Period, the Employee will be entitled to
participate in any fringe benefit welfare benefit plan of the Company (on the same terms as
provided to other employees of the Company), including any plan providing for employee stock
purchases, pension or retirement income, retirement savings, employee stock ownership, deferred
compensation or medical, prescription, dental, disability, employee life, group life, accidental
death or travel accident insurance benefits that the Company may adopt for the benefit of
employees, in accordance with the terms of such plan. Nothing in this Agreement shall restrict the
right of the Company to change insurance carriers and to adopt, amend, terminate or modify employee
benefit plans and arrangements at any time and without the consent of the Employee.

               (d) Stock Options. The Company may grant options to purchase the stock of the Company
to the Employee in accordance with the terms of the Company’s stock option plans.

               (e) Vacation; Holidays. The Employee shall be entitled to all public holidays
observed by the Company and to annual vacation for such number of days as may be determined by the
Company, and otherwise in accordance with the applicable vacation policies for senior executives of
the Company, which shall be taken at a reasonable time or times.

               (f) Withholding Taxes and Other Deductions. To the extent required by law, the
Company shall withhold from any payments due Employee under this Agreement any applicable federal,
state or local taxes and such other deductions as are prescribed by law or Company policy or are
otherwise authorized by the Employee.

          6. Expenses. The Employee is expected and is authorized to incur reasonable expenses
in the performance of his duties hereunder. The Company shall reimburse the Employee for all such
expenses in accordance with the Company’s expense reimbursement policy, upon periodic presentation
by the Employee of an itemized account, including reasonable substantiation, of such expenses.

          7. Confidentiality, Non-Disclosure and Non-Competition Agreement.

          Concurrently with the execution of this Agreement, the parties are entering into an Employee
Covenants Agreement (the “Related Agreement”).

          8. Termination of Employment.

               (a) Permitted Terminations. The Employee’s employment hereunder may be terminated
during the Employment Period under the following circumstances:

	 	i.	 	Death. The Employee’s employment hereunder
shall terminate upon the Employee’s death;
	 
	 	ii.	 	By the Company. The Company may terminate the
Employee’s employment:

	 	a.	 	If the Employee shall have been
substantially unable to perform the Employee’s material duties
hereunder by reason of illness, physical or mental disability or
other similar incapacity, which inability shall continue for three
consecutive

 

 

	 	 	 	months (provided, that until such termination, the
Employee shall continue to receive his compensation and benefits
hereunder, reduced by any benefits payable to him or her under any
disability insurance policy or plan applicable to him or her); or
	 
	 	b.	 	For Cause;

	 	iii.	 	By the Employee. The Employee may terminate
his employment for any reason or for no reason.

               (b) Termination. Any termination of the Employee’s employment by the Company or the
Employee (other than because of the Employee’s death) shall be communicated by written Notice of
Termination to the other party hereto in accordance with Section 10 hereof. For purposes of this
Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific
termination provision in this Agreement relied upon, if any, and shall set forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of the Employee’s
employment under the provision so indicated. Termination of the Employee’s employment shall take
effect on the Date of Termination.

          9. Compensation Upon Termination or Change in Control.

               (a) Death. If the Employee’s employment is terminated during the Employment Period as
a result of the Employee’s death, the Company shall pay to the Employee’s estate, or as may be
directed by the legal representatives of such estate, the Employee’s Base Salary due through the
Date of Termination, a pro rata portion of the annual bonus that would have been payable for the
calendar year of termination if the Employee’s employment had not terminated (calculated based upon
actual results through the Date of Termination and based upon budget for the remainder of the
period and pro rated for the portion of the year during which the Employee was employed) and all
other unpaid amounts, if any, to which the Employee is entitled as of the Date of Termination, at
the time such payments are due, and the Company shall have no further obligation to the Employee
under this Agreement.

               (b) Disability. If the Company terminates the Employee’s employment during the
Employment Period because of the Employee’s disability pursuant to Section 8(a)(ii)(A) hereof, the
Company shall pay the Employee the Employee’s Base Salary due through the Date of Termination, a
pro rata portion of the annual bonus that would have been payable for the calendar year of
termination if the Employee’s employment had not terminated (calculated based upon actual results
through the Date of Termination and based upon budget for the remainder of the period and pro rated
for the portion of the year during which the Employee was employed) and all other unpaid amounts,
if any, to which the Employee is entitled as of the Date of Termination, at the time such payments
are due, and the Company shall have no further obligations to the Employee under this Agreement;
provided, that payments so made to the Employee with respect to any period that the
Employee is substantially unable to perform the Employee’s material duties hereunder by reason of
illness, physical or mental illness or other similar incapacity shall be reduced by the sum of the
amounts, if any, payable to the Employee by reason of such disability, at or prior to the time of
any such payment, under any disability insurance policy or benefit plan and which amounts have not
previously been applied to reduce any such payment.

               (c) Termination by the Company for Cause or by the Employee without Good Reason. If,
during the Employment Period, the Company terminates the Employee’s employment for Cause pursuant
to Section 8(a)(ii)(B) hereof or the Employee terminates his employment without Good Reason, the
Company shall pay the Employee the Employee’s Base Salary due through the Date of Termination, and
all other unpaid amounts, if any, to which the Employee is entitled as of the Date of Termination,
at the time such payments are due, and the Company shall have no further obligations to the
Employee under this Agreement. In the event that the Company intends to terminate the Employee for
Cause, the Employee shall have a reasonable opportunity, together with his counsel, to be heard
before the Board of Directors of the Company before such termination.

               (d) Termination by the Company without Cause or by the Employee with Good Reason.
Subject to Section 9(e) below, if the Company terminates the Employee’s employment during the
Employment Period other than for Cause, disability or death pursuant to Section 8(a)(i) or
(ii) hereof or the Employee terminates employment hereunder with Good Reason, the Company shall (i)
pay the Employee the

 

 

Employee’s Base Salary due through the Date of Termination, a pro rata portion
of the annual bonus that would have been payable for the calendar year of termination if the
Employee’s employment had not terminated (calculated based upon actual results through the Date of
Termination and based upon budget for the remainder of the period and pro rated for the portion of
the year during which the Employee was employed) and all other unpaid amounts, if any, to which the
Employee is entitled as of the Date of Termination, at the time such payments are due, (ii) pay,
during the 12-month period commencing on the Date of Termination (the “Severance Period”), to the
Employee an aggregate amount equal to Employee’s Base Salary, payable in equal installments on the
Company’s regular salary payment dates, (iii) shall continue in effect during the Severance Period
the employee benefits provided to the Employee under Section 5(c) hereof immediately before the
Date of Termination (except to that, to the extent such benefits are provided pursuant to a
qualified plan under Section 401(a) of the Code, the Company shall provide a substantially
equivalent nonqualified benefit) and (iv) if such termination occurs within two years after a
Change in Control (or before a Change in Control has occurred, but after the Company has commenced
negotiations of a transaction that results in a Change in Control), shall cause all of the
outstanding options then held by the Employee to purchase stock of the Company to be fully vested
and exercisable; provided, notwithstanding anything herein to the contrary, the provision for
acceleration of options described in this paragraph will not apply to any options, restricted
stock, SAR or other awards approved by the S1 Board of Directors and/or granted to Employee on or
about November 1, 2006; provided further, that no notice of Non-Renewal shall be deemed to be a
termination of the Employee’s employment for such purposes unless otherwise expressly provided in
such notice of Non-Renewal. As a condition precedent to the receipt of the foregoing payments and
benefits, if requested by the Company, the Employee shall enter into an agreement with the Company
confirming the Company’s right to continued performance by the Employee of the Employee’s
obligations under the Related Agreement during the period following termination of the Employee’s
employment.

               (e) Limitation on Parachute Payments. Notwithstanding any other provision of this
Agreement or of any other agreement, contract, or understanding heretofore or hereafter entered
into by the Employee with the Company or any subsidiary or affiliate, except an agreement,
contract, or understanding hereafter entered into that expressly modifies or excludes application
of this paragraph (an “Other Agreement”), and notwithstanding any formal or informal plan or other
arrangement for the direct or indirect provision of compensation to the Employee (including groups
or classes of participants or beneficiaries of which the Employee is a member), whether or not such
compensation is deferred, is in cash, or is in the form of a benefit to or for the Employee (a
“Benefit Arrangement”), if the Employee is a “disqualified individual,” as defined in Section
280G(c) of the Code, no payment or benefit shall be made or provided to the Employee or become
vested, exercisable or payable, as applicable, (i) to the extent that such payment, right to
exercise, vesting, or other benefit, taking into account all other payments, rights, or benefits to
or for the Employee, or becoming vested, exercisable or payable, as the case may be, under this
Agreement, all Other Agreements and all Benefit Arrangements, would cause any such payment, right
to exercise, vesting or other benefit to which the Employee is or would be entitled under this
Agreement to be considered a “parachute payment” within the meaning of Section 280G(b)(2) of the
Code as then in effect (a “Parachute Payment”) and (ii) if, as a result of receiving a
Parachute Payment, the aggregate after-tax amounts received by the Employee under this Agreement,
all Other Agreements, and all Benefit Arrangements would be less than the maximum after-tax amount
that could be received by the Employee without causing any such payment, right to exercise, vesting
or other benefit to be considered a Parachute Payment. In the event that the receipt of any such
payment, right to exercise, vesting, or other benefit under this Agreement, in conjunction with all
other rights, payments, or benefits to or for the Employee under any Other Agreement or any Benefit
Arrangement would cause the Employee to be considered to have received a Parachute Payment under
this Agreement that would have the effect of decreasing the after-tax amount received by the
Employee as described in clause (ii) of the preceding sentence, then the Employee shall have the
right, in the Employee’s sole discretion, to designate those rights, payments or benefits (or the
vesting or exercisability thereof) under this Agreement, any Other Agreements and any Benefit
Arrangements that should be reduced or eliminated so as to avoid having the right, payment or
benefit to the Employee (or the vesting or exercisability thereof) under this Agreement be deemed
to be a Parachute Payment. All determinations required to be made under this Section 9(e),
including whether and when a reduction in rights, payments or benefits (or the vesting or
exercisability thereof) is required and the amount of such reduction and the assumptions to be
utilized in arriving at such determination, shall be made by PricewaterhouseCoopers LLP or such
other certified public accounting firm reasonably acceptable to the Company as may be designated by
the Employee in writing (the “Accounting Firm”) which shall provide detailed
supporting calculations both to the Company and the Employee within 15 business days of the
receipt of notice from the Employee or the Company. In the event that the Accounting Firm is
serving as accountant or auditor for the Company or any individual, entity or group effecting a
change in the ownership or effective control of the Company (within the meaning of Section 280G of
the Code), the Employee shall appoint another nationally recognized

 

 

accounting firm that is
reasonably acceptable to the Company to make the determinations required hereunder (which
accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses
of the Accounting Firm shall be borne solely by the Company. Any determination by the Accounting
Firm shall be binding upon the Company and the Employee.

               (f) Liquidated Damages. The parties acknowledge and agree that damages which will
result to the Employee for termination by the Company without Cause or other breach of this
Agreement by the Company shall be extremely difficult or impossible to establish or prove, and
agree that the amounts payable to the Employee under Section 9(d) hereof (the “Severance Payments”)
shall constitute liquidated damages for any breach of this Agreement by the Company through the
Date of Termination. The Employee agrees that, except for such other payments and benefits to
which the Employee may be entitled as expressly provided by the terms of this Agreement or any
applicable benefit plan, such liquidated damages shall be in lieu of all other claims that the
Employee may make by reason of termination of his employment or any such breach of this Agreement
and that, as a condition to receiving the Severance Payments, the Employee will execute a release
of claims in a form reasonably satisfactory to the Company.

          10. Notices. All notices, demands, requests, or other communications which may be or
are required to be given, served, or sent by any party to any other party pursuant to this
Agreement shall be in writing and shall be hand delivered, sent by overnight courier or mailed by
first-class, registered or certified mail, return receipt requested, postage prepaid, or
transmitted by telegram, telecopy or telex, addressed as follows:

	 	(i)	 	If to the Company:
	 
	 	 	 	S1 Corporation

3500 Lenox Road

Suite 200

Atlanta, GA 30326

Fax: 404 923 6717

Attn: Chief Legal Officer

          with a copy (which shall not constitute notice) to:

	 	 	 	Stuart G. Stein

Hogan & Hartson, L.L.P.

555 13th Street, N.W.

Washington, D.C. 20004-1190

Fax: 202/637-5910
	 
	 	(ii)	 	If to the Employee:

 

 

 

          Each party may designate by notice in writing a new address to which any notice, demand,
request or communication may thereafter be so given, served or sent. Each notice, demand, request,
or communication which shall be hand delivered, sent, mailed or telecopied in the manner described
above, or which shall be delivered to a telegraph company, shall be deemed sufficiently given,
served, sent, received or delivered for all purposes at such time as it is delivered to the
addressee (with the return receipt, the delivery receipt, or (with
respect to a telecopy) the answerback being deemed conclusive, but not exclusive, evidence of
such delivery) or at such time as delivery is refused by the addressee upon presentation.

          11. Severability. The invalidity or unenforceability of any one or more provisions of
this Agreement shall not affect the validity or enforceability of the other provisions of this
Agreement, which shall remain in full force and effect.

 

 

          12. Survival. It is the express intention and agreement of the parties hereto that
the provisions of Sections 9, 10, 11, 13, 17 and 20 hereof and this Section 12 shall survive the
termination of employment of the Employee. In addition, all obligations of the Company to make
payments hereunder shall survive any termination of this Agreement on the terms and conditions set
forth herein.

          13. Assignment. The rights and obligations of the parties to this Agreement shall not
be assignable or delegable, except that (i) in the event of the Employee’s death, the personal
representative or legatees or distributees of the Employee’s estate, as the case may be, shall have
the right to receive any amount owing and unpaid to the Employee hereunder and (ii) the rights and
obligations of the Company hereunder shall be assignable and delegable in connection with any
subsequent merger, consolidation, sale of all or substantially all of the assets or stock of the
Company or similar transaction involving the Company or a successor corporation. The Company shall
require any successor to the Company to expressly assume and agree to perform this Agreement in the
same manner and to the same extent that the Company would be required to perform it if no such
succession had taken place.

          14. Binding Effect. Subject to any provisions hereof restricting assignment, this
Agreement shall be binding upon the parties hereto and shall inure to the benefit of the parties
and their respective heirs, devisees, executors, administrators, legal representatives, successors
and assigns.

          15. Amendment; Waiver. This Agreement shall not be amended, altered or modified
except by an instrument in writing duly executed by the parties hereto. Neither the waiver by
either of the parties hereto of a breach of or a default under any of the provisions of this
Agreement, nor the failure of either of the parties, on one or more occasions, to enforce any of
the provisions of this Agreement or to exercise any right or privilege hereunder, shall thereafter
be construed as a waiver of any subsequent breach or default of a similar nature, or as a waiver of
any such provisions, rights or privileges hereunder.

          16. Headings. Section and subsection headings contained in this Agreement are
inserted for convenience of reference only, shall not be deemed to be a part of this Agreement for
any purpose, and shall not in any way define or affect the meaning, construction or scope of any of
the provisions hereof.

          17. Governing Law. This Agreement, the rights and obligations of the parties hereto,
and any claims or disputes relating thereto, shall be governed by and construed in accordance with
the laws of the State of Delaware (but not including any choice of law rule thereof that would
cause the laws of another jurisdiction to apply).

          18. Entire Agreement. This Agreement constitutes the entire agreement between the
parties respecting the employment of the Employee, there being no representations, warranties or
commitments except as set forth herein.

          19. Counterparts. This Agreement may be executed in two counterparts, each of which
shall be an original and all of which shall be deemed to constitute one and the same instrument.

          20. Definitions.

               “Accounting Firm” is defined in Section 9(e) above.

               “Agreement” means this Employment Agreement.

               “Base Salary” is defined in Section 5(a) above.

               “Benefit Arrangement” is defined in Section 9(e) above.

               “Board” means the board of directors of the Company.

               “Cause” means (i) the indictment by a grand jury or conviction of a felony or a crime
involving moral turpitude (excluding a traffic violation not involving any period of incarceration)
or the willful commission of any other act or omission involving dishonesty or fraud with respect
to, and materially adversely

 

 

affecting the business affairs of, the Company or any of its
Subsidiaries or any of their customers or suppliers, (ii) conduct tending to bring the Company or
any of its Subsidiaries into public disgrace or disrepute that is determined by the Company to
cause or be reasonably likely to cause substantial injury to the business and operations of the
Company or such Subsidiary, (iii) substantial and repeated failure to perform duties, including but
not limited to achieving quarterly goals, of the office held by the Employee as reasonably directed
by the Company (other than any such failure resulting from the Employee’s incapacity due to injury
or illness), and such failure is not cured within 30 days after the Employee receives written
notice thereof from the Company that specifically identifies the manner in which the Company
believes the Employee has not substantially performed his duties, (iv) gross negligence or willful
misconduct with respect to the Company or any of its Subsidiaries that causes substantial and
material injury to the business and operations of the Company or such Subsidiary or (v) any
material breach of the Related Agreement. For purposes of this provision, no act or failure to
act, on the part of the Employee, shall be considered “willful” unless it is done, or omitted to be
done, by the Employee in bad faith or without reasonable belief that the Employee’s action or
omission was in the best interests of the Company. Any act, or failure to act, based upon
authority given pursuant to a resolution duly adopted by the Board or based upon advice of counsel
for the Company shall be conclusively presumed to be done, or omitted to be done, by the Employee
in good faith and in the best interests of the Company.

               “Change in Control” means the earliest to occur of the following: (i) any person
(other than a corporation (a “Holding Company”) all of the common stock of which is owned,
immediately after the transaction, by persons who owned more than 50 percent of the voting shares
of the Company immediately before the transaction) becomes the beneficial owner of 50 percent or
more of the total number of voting shares of the Company; (ii) any person (other than the persons
named as proxies solicited on behalf of the Board) holds revocable or irrevocable proxies, as to
the election or removal of two or more directors of the Company, for more than 50 percent of the
total number of voting shares of the Company; (iii) any person (other than a Holding Company) has
commenced a tender or exchange offer, or entered into an agreement or received an option, to
acquire beneficial ownership of more than 50 percent of the total number of voting shares of the
Company; (iv) there is a sale or other transfer of all or substantially all of the assets of the
Company other than to a Holding Company or a corporation controlled by the Company or (v) as the
result of, or in connection with, any cash tender or exchange offer, merger, or other business
combination, sale of assets or contested election, or any combination of the foregoing
transactions, the persons who were directors of the Company before such transaction shall cease to
constitute at least a majority of the Board or any successor corporation. In the event that the
Company (or any successor entity) becomes a subsidiary of a Holding Company, references to the
Company in the preceding sentence shall be deemed to be references to the Holding Company.
Notwithstanding the foregoing, a “Change in Control” will not be deemed to have occurred under
clauses (ii) or (iii) above if within 30 days of such action, the Board (by a two-thirds
affirmative vote of the directors in office before such action occurred) makes a determination that
such action does not and is not likely to constitute a change in control of the Company. For
purposes of this definition, a “person” includes an individual, corporation, partnership, trust,
association, joint venture, pool, syndicate, unincorporated organization, joint-stock company, or
similar organization or group acting in concert. A person for these purposes shall be deemed to be
a beneficial owner as that term is used in Rule 13d-3 under the Securities Exchange Act of 1934, as
amended.

               “Code” means the Internal Revenue Code of 1986, as amended.

               “Company” means S1 Corporation and its successors and assigns.

               “Date of Termination” means (i) if the Employee’s employment is terminated by the
Employee’s death, the date of the Employee’s death; (ii) if the Employee’s employment is terminated
because of the Employee’s disability pursuant to Section 8(a)(ii)(A) hereof, 30 days after Notice
of Termination, provided that the Employee shall not have returned to the performance of the
Employee’s duties on a full-time basis during such
30-day period; (iii) if the Employee’s employment is terminated by the Company for Cause
pursuant to Section 8(a)(ii)(B) hereof or by the Employee pursuant to Section 8(a)(iii) hereof, the
date specified in the Notice of Termination; or (iv) if the Employee’s employment is terminated
during the Employment Period other than pursuant to Section 8(a), the date on which Notice of
Termination is given.

               “Effective Date” means December 1, 2006.

               “Employment Period” is defined in Section 2 above.

 

 

               “Employee” means Neil Underwood

               “Good Reason” means (i) the Company’s failure to perform or observe any of the
material terms or provisions of this Agreement, and the continued failure of the Company to cure
such default within 30 days after written demand for performance has been given to the Company by
the Employee, which demand shall describe specifically the nature of such alleged failure to
perform or observe such material terms or provisions; (ii) a change in the Employee’s reporting,
duties and/or job title where there is no reduction in the Employee’s Base Salary or Annual Bonus
potential shall not be determined to be Good Reason under this Agreement; (iii) any requirement by
the Company without the written consent of the Employee that the Employee relocate to a place more
than 50 miles from Atlanta, Georgia to perform his duties hereunder; or (iv) the failure of the
Company to obtain the assumption of the Company’s obligations under this Agreement by a successor
as contemplated by Section 13 of this Agreement.

               “Initial Term” is defined in Section 2 above.

               “Non-Renewal” is defined in Section 2 above.

               “Notice of Termination” is defined in Section 8(b) above.

               “Other Agreement” is defined in Section 9(e) above.

               “Parachute Payment” is defined in Section 9(e) above.

               “Related Agreement” is defined in Section 7 above.

               “Severance Period” is defined in Section 9(d) above.

               “Subsidiary” means any corporation of which the Company owns securities having a
majority of the ordinary voting power in electing the board of directors directly or through one or
more subsidiaries and any partnership, limited liability company or other entity in which the
Company or any subsidiary owns a controlling interest.

          IN WITNESS WHEREOF, the undersigned have duly executed and delivered this Agreement, or have
caused this Agreement to be duly executed and delivered on their behalf, as of the Effective Date.

	 	 	 	 	 
	 	S1 CORPORATION

 	 
	 	By:  	/s/ Johann Dreyer
 	 
	 	 	President and Chief Executive Officer 	 
	 
	 	THE EMPLOYEE:

 	 
	 	/s/ Neil Underwood
 	 

 

 

	 	 	 	 	 

CONFIDENTIALITY, NON-DISCLOSURE

AND NON-SOLICITATION AGREEMENT

          In consideration and as a condition of my employment by S1 Corporation, a Delaware corporation
(the “Company”, which term shall also include any subsidiaries and divisions of S1 Corporation), I
hereby agree with the Company as follows:

          1. Nondisclosure and Use of Proprietary Information.

          (a) I represent and warrant that: (i) I am not subject to any legal or contractual duty or
agreement that would prevent me from performing my duties for the Company or complying with this
Agreement, and I am not in breach of any legal or contractual duty or agreement, including any
agreement concerning trade secrets or confidential information owned by any other party.

          (b) I will not: use, disclose, or reverse engineer the Trade Secrets or the Confidential
Information, except as authorized in writing by the Company; (ii) during my employment with the
Company, use, disclose, or reverse engineer (A) any confidential information or trade secrets of
any former employer or third party, or (B) any works of authorship developed in whole or in part by
me during any former employment or for any other party, unless authorized in writing by the former
employer or third party; or (iii) upon my resignation or termination, (A) retain Trade Secrets or
Confidential Information, including any copies existing in any form (including electronic form)
which are in my possession or control, or (B) destroy, delete, or alter the Trade Secrets or
Confidential Information without the Company’s written consent.

          (c) The obligations under this Agreement shall (i) with regard to the Trade Secrets, remain in
effect as long as the information constitutes a trade secret under applicable law; and (ii) with
regard to the Confidential Information, remain in effect during the Restricted Period.

          (d) The confidentiality, property, and proprietary rights protections available in this
Agreement are in addition to, and not exclusive of, any and all other rights to which the Company
is entitled under federal and state law, including, but not limited to, rights provided under
copyright laws, trade secret and confidential information laws, and laws concerning fiduciary
duties.

          (e) For purposes of this Agreement, the following definitions shall apply:

               (i) “Confidential Information” means (a) information of the Company, to the extent not
considered a Trade Secret under applicable law, that (i) relates to the business of the Company,
(ii) possesses an element of value to the Company, (iii) is not generally known to the Company’s
competitors, and (iv) would damage the Company if disclosed, and (b) information of any third party
provided to the Company which the Company is obligated to treat as confidential. Confidential
Information includes, but is not limited to, (i) future business plans, (ii) the composition,
description, schematic or design of products, future products or equipment of the Company, (iii)
communication systems, audio systems, system designs and related documentation, (iv) advertising or
marketing plans, (v) information regarding independent contractors, employees, clients and
customers of the Company, and (vi) information concerning the Company’s financial structure and
methods and procedures of operation. Confidential Information shall not include any information
that (a) is or becomes generally available to the public other than as a result of an unauthorized
disclosure, (b) has been independently developed and disclosed by others without violating this
Agreement or the legal rights of any party, or (c) otherwise enters the public domain through
lawful means.

               (ii) “Restricted Period” means the time period during my employment with the Company, and for
one (1) year after my employment with the Company ends.

               (iii) “Trade Secrets” means information of the Company, and its licensors, suppliers, clients
and customers, without regard to form, including, but not limited to, technical or nontechnical
data, a formula, a pattern, a compilation, a program, a device, a method, a technique, a drawing, a
process, financial data, financial plans, product plans, or a list of actual or potential customers or
suppliers which is not commonly known

 

 

by or available to the public and which information (i)
derives economic value, actual or potential, from not being generally known to, and not being
readily ascertainable by proper means by, other persons who can obtain economic value from its
disclosure or use, and (ii) is the subject of efforts that are reasonable under the circumstances
to maintain its secrecy.

          2. Assignment of Developments.

          (a) I understand that my employment duties may include inventing in areas directly or
indirectly related to the business of the Company or to a line of business that the Company may
reasonably be interested in pursuing. All Work Product shall constitute work made for hire. If
(i) any of the Work Product may not be considered work made for hire, or (ii) ownership of all
right, title, and interest in and to the Work Product will not vest exclusively in the Company,
then, without further consideration, I assign all presently-existing Work Product to the Company,
and agree to assign, and automatically assign, all future Work Product to the Company.

          (b) The Company will have the right to obtain and hold in its own name copyrights, patents,
design registrations and continuations thereof, proprietary database rights, trademarks, rights of
publicity, and any other protection available in the Work Product. At the Company’s request, I
agree to perform, during or after my employment with the Company, any acts to transfer, perfect and
defend the Company’s ownership of the Work Product, including, but not limited to: (i) executing
all documents (including a formal assignment to the Company) for filing an application or
registration for protection of the Work Product (an “Application”), (ii) explaining the nature of
the Work Product to persons designated by the Company, (iii) reviewing Applications and other
related papers, or (iv) providing any other assistance reasonably required for the orderly
prosecution of Applications. I agree to provide the Company with a written description of any Work
Product in which I am involved (solely or jointly with others) and the circumstances surrounding
the creation of such Work Product.

          (c) During my employment and after my employment with the Company ends, I grant to the Company
an irrevocable, nonexclusive, worldwide, royalty-free license to: (i) make, use, sell, copy,
perform, display, distribute, or otherwise utilize copies of the Licensed Materials, (ii) prepare,
use and distribute derivative works based upon the Licensed Materials, and (iii) authorize others
to do the same. I will notify the Company in writing of any Licensed Materials I deliver to the
Company.

          (d) For purposes of this Agreement, the following definitions shall apply:

               (i) “Licensed Materials” means any materials that I utilize for the benefit of the Company, or
deliver to the Company or the Company’s customers, which (i) do not constitute Work Product, (ii)
are created by me or of which I am otherwise in lawful possession, and (iii) I may lawfully utilize
for the benefit of, or distribute to, the Company or the Company’s customers.

               (ii) “Work Product” means (a) any data, databases, materials, documentation, computer
programs, inventions (whether or not patentable), designs, and/or works of authorship, including
but not limited to, discoveries, ideas, concepts, properties, formulas, compositions, methods,
programs, procedures, systems, techniques, products, improvements, innovations, writings, pictures,
audio, video, images of me, and artistic works, and (b) any subject matter protected under patent,
copyright, proprietary database, trademark, trade secret, rights of publicity, confidential
information, or other property rights, including all worldwide rights therein, that is or was
conceived, created or developed in whole or in part by me while employed by the Company and that
either (i) is created within the scope of my employment, (ii) is based on, results from, or is
suggested by any work performed within the scope of my employment and is directly or indirectly
related to the business of the Company or a line of business that the Company may reasonably be
interested in pursuing, (iii) has been or will be paid for by the Company, or (iv) was created or
improved in whole or in part by using the Company’s time, resources, data, facilities, or
equipment.

          3. Non-Solicitation.

          (a) During the Restricted Period, I will not, directly or indirectly, solicit, recruit or
induce any Employee to (i) terminate his employment relationship with the Company, or (ii) work for
any other person or entity engaged in the Business.

 

 

          (b) During the Restricted Period, I will not directly or indirectly solicit any Customer of
the Company for the purpose of providing any goods or services competitive with the Business. The
restrictions set forth in this Section apply only to Customers with whom I had Contact.

          (c) For purposes of this Agreement, the following definitions shall apply:

               (i) “Business” shall mean the business of developing, designing, and implementing computer
applications that allow banks, brokerage firms, and insurance companies to enable their customers
to access financial information and conduct transactions over multiple delivery channels.

               (ii) “Contact” means any interaction between a Customer and me which (i) takes place in an
effort to establish, maintain, and/or further a business relationship on behalf of the Company and
(ii) occurs during the last year of my employment with the Company (or during my employment if
employed less than a year).

               (iii) “Customer” means any person or entity to whom the Company has sold its products or
services, or solicited to sell its products or services.

               (iv) “Employee” means any person who (i) is employed by the Company at the time my employment
with the Company ends, (ii) was employed by the Company during the last year of my employment with
the Company (or during my employment if employed less than a year), or (iii) is employed by the
Company during the Restricted Period.

          4. Equitable Relief.

          If I breach this Agreement, I agree that: (a) the Company would suffer irreparable harm; (b)
it would be difficult to determine damages, and money damages alone would be an inadequate remedy
for the injuries suffered by the Company; and (c) if the Company seeks injunctive relief to
enforce this Agreement, I will waive and will not (i) assert any defense that the Company has an
adequate remedy at law with respect to the breach, (ii) require that the Company submit proof of
the economic value of any Trade Secret or Confidential Information, or (iii) require the Company to
post a bond or any other security. Nothing contained in this Agreement shall limit the Company’s
right to any other remedies at law or in equity.

          5. No Right to Continued Employment.

          I understand that this Agreement does not create a contract of employment or a contract for
benefits. Except as set forth in a separate agreement duly authorized and executed by the Company,
my employment relationship with the Company is at-will. This means that at either my option or the
Company’s option, my employment may be terminated at any time, with or without cause or notice.

          6. Attorneys’ Fees

          In the event of litigation relating to this Agreement, the Company shall, if it is the
prevailing party, be entitled to recover attorneys’ fees and costs of litigation in addition to all
other remedies available at law or in equity.

          7. Waivers.

          Any waiver by the Company of a breach of any provision of this Agreement shall not operate or
be construed as a waiver of any subsequent breach of such provision or any other provision hereof.

 

 

          8. Acknowledgment; Severability.

          I acknowledge that the restrictions contained in this Agreement are reasonable and necessary
to protect the legitimate business interests of the Company, and will not impair or infringe upon
my right to work or earn a living in the event my employment with the Company ends. The provisions
of this Agreement are severable. If any provision is determined to be invalid, illegal, or
unenforceable, in whole or in part, the remaining provisions and any partially enforceable
provisions shall remain in full force and effect.

          9. Survival of Obligations.

          I understand that I shall not have the right to assign my rights or obligations under this
Agreement. My obligations under this Agreement shall survive the termination of my employment
regardless of the manner of, or reason for, such termination.

          10. Assignment.

          This Agreement shall be assignable to, and shall inure to the benefit of, the Company’s
successors and assigns, including, without limitation, successors through merger, name change,
consolidation, or sale of a majority of the Company’s stock or assets, and shall be binding upon
me.

          11. Governing Law.

          The laws of the State of Delaware shall govern this Agreement. If Delaware’s conflict of law
rules would apply another state’s laws, the Company and I agree that Delaware law shall still
govern.

          12. Entire Agreement.

          This Agreement constitutes the entire agreement between the Company and me concerning the
subject matter of this Agreement. This Agreement supersedes any prior communications, agreements
or understandings, whether oral or written, between the Company and me relating to the subject
matter of this Agreement.

          13. Consent to Jurisdiction.

          I agree that any claim arising out of or relating to this Agreement shall be brought in a
state or federal court of competent jurisdiction in Atlanta, Georgia. I consent to the personal
jurisdiction of the state and/or federal courts located in Georgia. I waive (a) any objection to
jurisdiction or venue, or (b) any defense claiming lack of jurisdiction or improper venue, in any
action brought in such courts.

          IN WITNESS WHEREOF, the undersigned has executed this
Confidentiality, Non-Disclosure and Non-Solicitation Agreement as of the 1st day of
December, 2006.

	 	 	 	 	 
	 	 	 
	 	/s/ Neil Underwood
 	 
	 	Signature 	 
	 
	 	Name: 	Neil Underwood
 	 
	 	
 	 
	 	
 	 
	 	Address 	 
	 	 	 

 

 

	 	 	 	 	 

	 	 	 	 	 
	Agreed to and Accepted:

S1 CORPORATION

 	 	 
	By:  	/s/ Johann Dreyer
 	 	 
	 	President and Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]